Skip to main content

Developmental and light regulation of tumor suppressor protein PP2A in the retina.

Citation
Rajala, A., et al. “Developmental And Light Regulation Of Tumor Suppressor Protein Pp2A In The Retina.”. Oncotarget, pp. 1505-1523.
Center University of Michigan
Author Ammaji Rajala, Yuhong Wang, Steven F Abcouwer, Thomas W Gardner, Raju S Rajala V
Keywords Gerotarget, anti-oncogene, mechanistic target of rapamycin, protein kinase C, protein phosphatase-2A, retina
Abstract

Protein phosphatases are a group of universal enzymes that are responsible for the dephosphorylation of various proteins and enzymes in cells. Cellular signal transduction events are largely governed by the phosphorylation of key proteins. The length of cellular response depends on the activation of protein phosphatase that dephosphorylates the phosphate groups to halt a biological response, and fine-tune the defined cellular outcome. Dysregulation of these phosphatase(s) results in various disease phenotypes. The retina is a post-mitotic tissue, and oncogenic tyrosine and serine/ threonine kinase activities are important for retinal neuron survival. Aberrant activation of protein phosphatase(s) may have a negative effect on retinal neurons. In the current study, we characterized tumor suppressor protein phosphatase 2 (PP2A), a major serine/ threonine kinase with a broad substrate specificity. Our data suggest that PP2A is developmentally regulated in the retina, localized predominantly in the inner retina, and expressed in photoreceptor inner segments. Our findings indicate that PKCα and mTOR may serve as PP2A substrates. We found that light regulates PP2A activity. Our studies also suggest that rhodopsin regulates PP2A and its substrate(s) dephosphorylation. PP2A substrate phosphorylation is increased in mice lacking the A-subunit of PP2A. However, there is no accompanying effect on retina structure and function. Together, our findings suggest that controlling the activity of PP2A in the retina may be neuroprotective.

Year of Publication
2018
Journal
Oncotarget
Volume
9
Issue
2
Number of Pages
1505-1523
Date Published
01/2018
ISSN Number
1949-2553
DOI
10.18632/oncotarget.23351
Alternate Journal
Oncotarget
PMID
29416710
PMCID
PMC5788578
Download citation